Although S1PR3 up-regulation occurs in activated astrocytes, the role of S1PR-3 in producing significant cardiovascular effects, via its regulation of the KACh potassium channel [47,48,49,50], has diminished interest in it as a target for modulation in MS. Here, S1PR3 is linked to myeloid sarcoma.